Funder
Bill and Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. World Health Organisation. The End TB Strategy. Geneva, Switzerland: World Health Organisation (2015).
2. Dye, C, Glaziou, P., Floyd, K. & Raviglione, M. Prospects for tuberculosis elimination. Annu Rev Public Health. 34, 271–86. Epub 2012/12/19. PubMed PMID: 23244049,
https://doi.org/10.1146/annurev-publhealth-031912-114431
(2013).
3. Smieja, M. J., Marchetti, C. A., Cook, D. J. & Smaill, F. M. Isoniazid for preventing tuberculosis in non-HIV infected persons (Review). The Cochrane Library. 2 (2005).
4. Sterling, T. et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. NEJM. 365(23) (2011).
5. Houben, R. M. & Dodd, P. J. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med. 13(10), e1002152,
https://doi.org/10.1371/journal.pmed.1002152.
PubMed PMID: 27780211, PubMed Central PMCID: PMC5079585 (2016).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献